Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis

被引:16
|
作者
Klaver, Y. L. B. [1 ]
Lemmens, V. E. P. P. [2 ]
de Hingh, I. H. J. T. [3 ]
机构
[1] Catlzarina Hosp, Dept Med Oncol, NL-5602 ZA Eindhoven, Netherlands
[2] Comprehens Canc Ctr South, Dept Res, NL-5600 AE Eindhoven, Netherlands
[3] Catharina Hosp, Dept Surg, NL-5602 ZA Eindhoven, Netherlands
来源
EJSO | 2013年 / 39卷 / 07期
关键词
Peritoneal carcinomatosis; Colorectal cancer; Surgery; Complications; Survival; Outcome; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; IMPROVED SURVIVAL; ORIGIN; METASTASES; SELECTION; RISK; CT;
D O I
10.1016/j.ejso.2013.03.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The detection of peritoneal carcinomatosis (PC) in colorectal cancer patients frequently results in a dilemma with regard to the optimal treatment strategy, especially when PC is encountered unexpectedly during surgery. The aim of this study was to evaluate outcomes of patients undergoing surgery for colorectal carcinoma in the presence of synchronous PC. Methods: Patients diagnosed with primary colorectal cancer and synchronous PC in three community hospitals were selected from the Eindhoven Cancer Registry database. Outcomes of postoperative complications, in-hospital mortality and overall survival were collected and analyzed according to the type of intervention performed. Results: Between 1995 and 2009, 169 colorectal cancer patients were diagnosed with synchronous PC, most of them unexpectedly during surgery (n = 130). 142 patients underwent surgery: primary tumor resection (n = 91), palliative procedure (n = 46) or exploration only (n = 5). In-hospital mortality was 41% after palliative surgery and 14% after primary tumor resection. Median survival was 12 weeks after palliative surgery or exploration as opposed to 55 weeks after primary tumor resection. Conclusion: PC is most often encountered unexpectedly during surgery for colorectal cancer. Results of palliative procedures are very poor with a high in-hospital mortality rate and short survival. Resection of the primary tumor can be performed safely with relatively good outcomes but some patients could have benefited from an even more radical approach when the presence of PC would have been diagnosed at an earlier stage. Improvement of imaging techniques to detect PC prior to surgery is therefore urgently needed. Until this is the case, a high index of suspicion is required when subtle signs of PC are encountered. Keywords: Colorectal cancer, Metastasis, Peritoneal carcinomatosis, Surgery (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:734 / 741
页数:8
相关论文
共 50 条
  • [1] Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer
    Segelman, J.
    Akre, O.
    Gustafsson, U. O.
    Bottai, M.
    Martling, A.
    COLORECTAL DISEASE, 2014, 16 (05) : 359 - 367
  • [2] Unresectable Peritoneal Carcinomatosis From Colorectal Cancer: A Single Center Experience
    Hompes, Daphne
    Boot, Henk
    Van Tinteren, Harm
    Verwaal, Victor
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (03) : 269 - 273
  • [3] Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer
    van Gestel, Y. R. B. M.
    Thomassen, I.
    Lemmens, V. E. P. P.
    Pruijt, J. F. M.
    van Herk-Sukel, M. P. P.
    Rutten, H. J. T.
    Creemers, G. J.
    de Hingh, I. H. J. T.
    EJSO, 2014, 40 (08): : 963 - 969
  • [4] Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer
    Behrenbruch, Corina
    Hollande, Frederic
    Thomson, Benjamin
    Michael, Michael
    Warrier, Satish K.
    Lynch, Craig
    Heriot, Alexander
    ANZ JOURNAL OF SURGERY, 2017, 87 (09) : 665 - 670
  • [5] Surgery for colorectal peritoneal carcinomatosis
    Chua, Terence C.
    Pelz, Joerg O. W.
    Morris, David L.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (03) : 277 - 285
  • [6] Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    van Eden, Wijntje J.
    Kok, Niels F.
    Jozwiak, Katarzyna
    Lahaye, Max L.
    Beets, Geerard L.
    van Leerdam, Monique E.
    Boot, Henk
    Aalbers, Arend G.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (05) : 477 - 487
  • [7] Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index
    Sun, Chun-Feng
    Tan, Zhong-Hua
    Shen, Chen
    Mao, Xiao-Ying
    Ge, Cheng-Chun
    Gao, Yan
    Hu, Chun-Hong
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (07) : 517 - 526
  • [8] Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
    Pinto, Amandine
    Hobeika, Christian
    Philis, Antoine
    Kirzin, Sylvain
    Carrere, Nicolas
    Ghouti, Laurent
    LANGENBECKS ARCHIVES OF SURGERY, 2019, 404 (04) : 477 - 488
  • [9] A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer
    Hompes, D.
    Aalbers, A.
    Boot, H.
    van Velthuysen, M. -L.
    Vogel, W.
    Prevoo, W.
    van Tinteren, H.
    Verwaal, V.
    COLORECTAL DISEASE, 2014, 16 (08) : O264 - O272
  • [10] KRAS Status in Patients With Colorectal Cancer Peritoneal Carcinomatosis and Its Impact on Outcome
    Gillern, Suzanne M.
    Chua, Terence C.
    Stojadinovic, Alexander
    Esquivel, Jesus
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 456 - 460